Ultralife Q3 EPS $0.02 vs $0.08; revenue $35.7M (-9.6%); backlog $78M

ULTRALIFE CORP

2024-Q3 EPS reported $0.37 revenue$120,604,000

GAAP diluted EPS $0.02, down from $0.08; net income $0.3M vs $1.3M Q3 2023.
Revenue $35.7M, down 9.6% YoY; Battery & Energy +1.9%, Communications Systems -58.2%.
Backlog $78.0M; debt reduced 33.4% to $8.0M from $12.1M at Q2 end.
Acquisition of Electrochem Solutions completed Oct 31; related costs $0.3M in Q3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.